Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
| (A)
MASS GENERAL BRIGHAM INCORPORATED |
043230035 | 7 | Yes | 0 | 0 | |
| (B)
BRIGHAM INC |
042921338 | 7 | Yes | 0 | 0 | |
| (C)
NEWTON-WELLESLEY HOSPITAL INC |
042103611 | 3 | Yes | 0 | 0 | |
| (D)
COOLEY DICKINSON HOSPITAL INC |
222617175 | 3 | Yes | 0 | 0 | |
| (E)
WENTWORTH-DOUGLASS HOSPITAL INC |
020260334 | 3 | Yes | 0 | 0 | |
|
Total 5
|
0 | 0 | ||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | 4,644,652,037 | 3,806,711,641 | 4,950,929,420 | 4,788,110,796 | 7,116,843,554 | 25,307,247,448 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | 4,644,652,037 | 3,806,711,641 | 4,950,929,420 | 4,788,110,796 | 7,116,843,554 | 25,307,247,448 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | 25,307,247,448 | |||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 4,644,652,037 | 3,806,711,641 | 4,950,929,420 | 4,788,110,796 | 7,116,843,554 | 25,307,247,448 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 147,388,005 | 337,944,923 | 253,243,043 | 276,989,936 | 304,165,037 | 1,319,730,944 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | 26,628,450,101 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2022 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2022 |
(iii) Distributable Amount for 2022 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2022 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2022 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2022: | ||||
| a From 2017....... | ||||
| b From 2018....... | ||||
| c From 2019....... | ||||
| d From 2020....... | ||||
| e From 2021....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2022 distributable amount | ||||
|
i
Carryover from 2017 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2022 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2022 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2022, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2022. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2023. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2018..... | ||||
| b Excess from 2019..... | ||||
| c Excess from 2020..... | ||||
| d Excess from 2021..... | ||||
| e Excess from 2022..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
| Return Reference | Explanation |
|---|---|
| SCHEDULE E QUESTION 3 | THE INSTITUTE PUBLISHES ITS NON-DISCRIMINATORY POLICY IN ITS ONLINE CATALOG, STUDENT HANDBOOK, AND PROGRAM MANUALS ON ITS WEBSITE, WWW.MGHIHP.EDU; THE CATALOG, STUDENT HANDBOOK, AND PROGRAM MANUALS CAN BE PROVIDED IN PRINTED FORMAT UPON REQUEST. AS PART OF ITS ORIENTATION, THE INSTITUTE NOTIFIES NEWLY MATRICULATED STUDENTS REGARDING THE WEB ADDRESS OF THE ONLINE CATALOG, STUDENT HANDBOOK, AND PROGRAM MANUALS. CONTINUING STUDENTS ALSO RECEIVE AN ANNUAL NOTICE REGARDING THE LOCATION OF THESE ONLINE DOCUMENTS. INDIVIDUALS INQUIRING ABOUT THE INSTITUTE'S PROGRAMS RECEIVE PROGRAM INFORMATION THAT STATES THE INSTITUTE'S NON-DISCRIMINATORY POLICY. THE INSTITUTE'S APPLICATION FOR ADMISSION ALSO INCLUDES A STATEMENT ON THIS POLICY. ALSO, TRI-ANNUALLY, ALL CURRENTLY ACTIVE STUDENTS ARE SENT A NOTICE WHICH INCLUDES OUR DISCRIMINATION INFORMATION. |
| SCHEDULE E LINE 6A | YES. THE INSTITUTE PARTICIPATES IN TITLE IV FEDERAL STUDENT AID, SPECIFICALLY IN THE DIRECT LENDING PROGRAM. THE INSTITUE EXTENDS FINANCIAL ASSISTANCE TO STUDENTS IN THE FORM OF GRANTS, LOANS, GRADUATE ASSISTANTSHIPS AND SCHOLARSHIPS IN ACCORDANCE WITH INSTITUTIONAL AND FEDERAL POLICY. THE SELECTION FROM THE QUALIFIED STUDENT POPULATION FOR GRANT AND SCHOLARSHIP AID IS BASED ON MERIT AND/OR NEED, AS SPECIFIED BY THE CRITERIA OF EACH GRANT AND SCHOLARSHIP. STUDENTS INDEPENDENTLY APPLY FOR GRADUATE ASSISTANTSHIPS AND ARE INFORMED OF SUCH OPPORTUNITIES AS THEY ARISE. LOAN QUALIFICATIONS ARE DETERMINED IN ACCORDANCE WITH FEDERAL POLICY. FINANCIAL AID AWARDS ARE MADE ON A NON-DISCRIMINATORY BASIS. |
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| FORM 990, PART III - PROGRAM SERVICE (ATTACHMENT 1) | PATIENT CARE: MASS GENERAL BRIGHAM OPERATES ACADEMIC MEDICAL CENTERS, COMMUNITY ACUTE CARE HOSPITALS, FACILITIES THAT PROVIDE BOTH INPATIENT AND OUTPATIENT MENTAL HEALTH SERVICES, URGENT CARE CENTERS, REHABILITATION MEDICINE AND LONG-TERM CARE SERVICES, PHYSICIAN ORGANIZATIONS, A HOME HEALTH AGENCY, NURSING HOMES AND A GRADUATE LEVEL PROGRAM FOR HEALTH PROFESSIONS. IN ADDITION, MASS GENERAL BRIGHAM IS A NONUNIVERSITY-BASED NON-PROFIT PRIVATE MEDICAL RESEARCH ENTERPRISE AND IS A PRINCIPAL TEACHING AFFILIATE OF THE MEDICAL AND DENTAL SCHOOLS OF HARVARD UNIVERSITY. FOR MANY YEARS, MASS GENERAL BRIGHAM HAS INVESTED IN THE DEVELOPMENT AND IMPLEMENTATION OF MULTIPLE SYSTEM-WIDE INITIATIVES THAT HAVE IMPROVED PATIENT CARE QUALITY AND OUTCOMES AND HAVE MANAGED THE GROWTH IN THE COST OF PATIENT CARE. NEVERTHELESS, THE UPWARD PRESSURE ON HEALTHCARE COSTS HAS CONTINUED BOTH NATIONALLY AND LOCALLY, AND GOVERNMENT AND COMMERCIAL PAYERS HAVE RESPONDED IN A NUMBER OF WAYS, INCLUDING EFFORTS TO CONTROL PROVIDER RATE INCREASES, THE EXPANDED USE OF ALTERNATIVE PAYMENT MODELS, SUCH AS ACCOUNTABLE CARE ORGANIZATIONS (ACOS), TIGHTER REFERRAL MANAGEMENT AND PRICE TRANSPARENCY INITIATIVES. TO ADDRESS THE FINANCIAL AND OPERATIONAL CHALLENGES THAT WILL RESULT FROM THESE MARKET CONDITIONS, MASS GENERAL BRIGHAM HAS REAFFIRMED A SYSTEM-WIDE STRATEGY THAT IS GROUNDED IN THE EXCELLENCE OF ITS ACADEMIC MEDICAL CENTERS, FOCUSED ON IMPROVED PATIENT OUTCOMES, PATIENT EXPERIENCE AND GLOBAL HEALTH IMPACT, SUPPORTED BY ITS HISTORICAL AND PLANNED INVESTMENTS IN DIGITAL HEALTH AND DATA ANALYTICS, POPULATION HEALTH, AMBULATORY CARE AND INSURANCE RISK MANAGEMENT AND SYMBOLIZED BY ITS RECENTLY ADOPTED SINGLE, INTEGRATED SYSTEM BRAND "MASS GENERAL BRIGHAM." THIS STRATEGY HAS THE FOLLOWING FIVE SYNERGISTIC PRIORITIES: 1. ENHANCE REGIONAL AND NATIONAL RECOGNITION OF BWH AND THE GENERAL AS THE "GO TO" DESTINATIONS FOR KEY CLINICAL SERVICES BY DEVELOPING CROSS-ACADEMIC, MULTIDISCIPLINARY, NEXT-GENERATION CENTERS OF EXCELLENCE. 2. DEVELOP NEW OPPORTUNITIES FOR NATIONAL AND INTERNATIONAL BUSINESS DEVELOPMENT THROUGH EXPANDED SYSTEM-WIDE EFFORTS TO ATTRACT PATIENTS TO BWH AND THE GENERAL AND TO PROVIDE REMOTE DIAGNOSTICS, REMOTE CARE DELIVERY AND ADVISORY SERVICES. 3. SUBSTANTIALLY INCREASE INNOVATIONS IN DIAGNOSTICS, THERAPEUTICS, DEVICES AND DATA ANALYTICS THAT ARE BROUGHT TO MARKET BY EXPANDING COMMERCIALIZATION INVESTMENTS AND INFRASTRUCTURE. 4. LEAD IN BUILDING AND IMPLEMENTING A NEW VALUE-BASED CARE OPERATING MODEL FOR PRIMARY, SECONDARY AND BEHAVIORAL HEALTH CARE THAT DELIVERS VALUE FOR PRICE, IMPROVES PATIENT ACCESS AND OUTCOMES AND GROWS CLINICAL VOLUME AND ATTRIBUTED LIVES BY OPTIMIZING THE USE OF MASS GENERAL BRIGHAM COMMUNITY ASSETS AND LEVERAGING ITS EXPERTISE IN POPULATION HEALTH MANAGEMENT AND ABILITY TO DESIGN INSURANCE PRODUCTS; AND 5. EXPAND THE IMPACT OF MASS GENERAL BRIGHAM ON LEADING COMMUNITY HEALTH ISSUES BY TAKING A MULTI-PRONGED APPROACH TO ADVANCE HEALTH EQUITY AND ADDRESS SOCIAL DETERMINANTS OF HEALTH IN TARGETED COMMUNITIES. THE MASS GENERAL BRIGHAM ACUTE CARE SECTOR INCLUDES TWO OF THE MOST WELL RESPECTED ACADEMIC MEDICAL CENTERS IN THE UNITED STATES, BWH AND THE GENERAL, AS WELL AS MEEI, AND SEVEN ACUTE CARE COMMUNITY HOSPITALS: CDH, BWFH, MVH, NCH, NWH, NSMC AND WDH. TOGETHER THESE (WITHOUT WDH WHICH IS LOCATED IN NH) FORM THE LARGEST ACUTE CARE DELIVERY SYSTEM IN EASTERN MASSACHUSETTS. BWH AND THE GENERAL ARE RENOWNED FOR THEIR EXCELLENCE IN PATIENT CARE, INNOVATIVE AND FAR-REACHING RESEARCH EFFORTS AND EDUCATIONAL PROGRAMS. BWH AND THE GENERAL SERVE BOTH AS COMMUNITY HOSPITALS FOR PORTIONS OF METROPOLITAN BOSTON AND AS PROVIDERS OF TERTIARY AND QUATERNARY SERVICES, PRIMARILY TO EASTERN MASSACHUSETTS AND ADJACENT PORTIONS OF CONTIGUOUS STATES, BUT ALSO TO THE REMAINDER OF MASSACHUSETTS, NEW ENGLAND, OTHER PARTS OF THE UNITED STATES AND OTHER NATIONS. SINCE A SIGNIFICANT PART OF THE PRIMARY SERVICE AREAS OF BWH AND THE GENERAL DO NOT OVERLAP, BOTH BWH AND THE GENERAL CONTINUE TO PROVIDE MANY OF THE SAME TERTIARY AND SECONDARY SERVICES. AMONG THE TERTIARY SERVICES THAT MASS GENERAL BRIGHAM OFFERS THROUGH BWH AND THE GENERAL ARE ALL FORMS OF ORGAN TRANSPLANTS, INCLUDING HEART, LUNG, HEART-LUNG, LIVER, KIDNEY, BONE MARROW, SMALL BOWEL AND PANCREAS TRANSPLANTS. THE BURN AND LEVEL I TRAUMA UNITS (FOR TREATMENT OF THE MOST SERIOUS CASES) AT BWH AND THE GENERAL REPRESENT TWO OF ONLY THREE SUCH UNITS IN MASSACHUSETTS AND ARE AMONG THE LARGEST IN NEW ENGLAND. BWH AND THE GENERAL ARE LEADING ACADEMIC MEDICAL CENTERS. MASS GENERAL BRIGHAM OFFERS HEALTH CARE FOR NEARLY EVERY MEDICAL NEED. PATIENTS CHOOSE TO COME TO MASS GENERAL BRIGHAM HOSPITALS FROM THE BOSTON AREA, BUT ALSO FROM ACROSS THE COUNTRY AND THROUGHOUT THE WORLD BECAUSE OF GROUNDBREAKING ACHIEVEMENTS, MEDICAL CARE AND THE HIGH DEGREE OF SPECIALIZATION PROVIDED. DURING THE FISCAL YEAR (FY) 2023, ENDING SEPTEMBER 30, 2023, MASS GENERAL BRIGHAM RECORDED 158,608 ADMISSIONS AND 1,151,543 PATIENT DAYS. AMBULATORY CARE: EACH OF MASS GENERAL BRIGHAM'S NINE ACUTE CARE HOSPITALS PROVIDES EMERGENCY, AMBULATORY AND OUTPATIENT CARE ACROSS MAJOR SPECIALTIES. COMBINED, THEY COMPRISE THE LARGEST OUTPATIENT NETWORK IN EASTERN MASSACHUSETTS. IN FY 2023, MASS GENERAL BRIGHAM ACUTE CARE HOSPITAL BASED AND NON-HOSPITAL BASED AMBULATORY CARE PROGRAMS RESULTED IN APPROXIMATELY 2,265,000 ROUTINE VISITS, APPROXIMATELY 457,000 EMERGENCY SERVICES VISITS AND APPROXIMATELY 450,000 HOME HEALTH VISITS. ACUTE CARE HOSPITAL SECTOR BWH BWH IS THE RESULT OF A 1975 MERGER OF THE PETER BENT BRIGHAM HOSPITAL, THE ROBERT BRECK BRIGHAM HOSPITAL AND THE BOSTON HOSPITAL FOR WOMEN, WHOSE INPATIENT FACILITIES WERE PHYSICALLY CONSOLIDATED IN 1980. IN THE 2023-24 U.S. NEWS & WORLD REPORT, BWH IS ON THE BEST HOSPITALS HONOR ROLL, #2 IN MASSACHUSETTS AND #2 IN THE BOSTON METRO AREA AND WAS NATIONALLY RANKED IN TWELVE ADULT SPECIALTIES AND RATED 'HIGH PERFORMING' IN EIGHTEEN PROCEDURES AND CONDITIONS INCLUDING CANCER; CARDIOLOGY, HEART & VASCULAR SURGERY; DIABETES AND ENDOCRINOLOGY; EAR, NOSE & THROAT; GASTROENTEROLOGY & GI SURGERY, GERIATRICS; NEPHROLOGY, NEUROLOGY AND NEUROSURGERY; OBSTETRICS & GYNECOLOGY; ORTHOPEDICS; PSYCHIATRY; PULMONOLOGY & LUNG SURGERY; RHEUMATOLOGY AND UROLOGY. BWH PROVIDES OUTPATIENT SERVICES, INCLUDING PRIMARY CARE, SPECIALTY CARE, DIAGNOSTICS, IMAGING AND AMBULATORY PROCEDURES AT NUMEROUS AMBULATORY PRACTICES IN VARIOUS LOCATIONS. FOUR PRACTICE SITES ON THE BWH DISTRIBUTED MAIN CAMPUS AND THE BRIGHAM AND WOMEN'S AMBULATORY CARE CENTER IN CHESTNUT HILL HOUSE THE MAJORITY OF THESE PRACTICES, AND THE REMAINDER ARE IN SATELLITES LOCATED SOUTHWEST AND SOUTH OF BOSTON, INCLUDING THE BRIGHAM AND WOMEN'S/MASS GENERAL HEALTH CARE CENTER LOCATED AT PATRIOT PLACE IN FOXBOROUGH, MASSACHUSETTS. IN ADDITION, BWH OPERATES NEIGHBORHOOD HEALTH CENTERS IN THE JAMAICA PLAIN SECTION OF BOSTON NEAR ITS HOSPITAL FACILITIES AND SERVES AS A REFERRAL FACILITY FOR BOTH HEALTH CENTERS. THESE COMMUNITY HEALTH CENTERS PROVIDE COMPREHENSIVE SERVICES SIMILAR TO THOSE OFFERED BY SATELLITE PRACTICES AND INCLUDE PRIMARY CARE, DENTISTRY, PEDIATRICS, PODIATRY, OBSTETRICS, GYNECOLOGY, MENTAL HEALTH, NUTRITION, OUTPATIENT SUBSTANCE ABUSE COUNSELING AND SOCIAL SERVICES. BWH IS LICENSED BY THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH (DPH) TO OPERATE 856 BEDS AS OF SEPTEMBER 30, 2023. PURSUANT TO A JOINT VENTURE IN ADULT ONCOLOGY BETWEEN BWH AND DANA FARBER CANCER INSTITUTE, INC. (DFCI), THIRTY BEDS THAT ARE ON DFCI'S LICENSE ARE LOCATED ON BWH'S MAIN CAMPUS AND ARE SUPPORTED BY BWH PURSUANT TO SERVICE CONTRACTS WITH DFCI. THE GENERAL ORIGINALLY A DIVISION OF MGH, WHICH WAS FOUNDED BY SPECIAL ACT OF THE MASSACHUSETTS LEGISLATURE IN 1811, THE GENERAL WAS SEPARATELY INCORPORATED AS A SUBSIDIARY OF MGH IN 1980. THE GENERAL HOSPITAL ADMITTED ITS FIRST PATIENT IN 1821. IT IS THE THIRD OLDEST GENERAL, NON-MILITARY HOSPITAL IN THE UNITED STATES AND THE OLDEST IN NEW ENGLAND. IN THE 2023-24 U.S. NEWS & WORLD REPORT, THE GENERAL IS ON THE BEST HOSPITALS HONOR ROLL, #1 IN MASSACHUSETTS AND #1 IN THE BOSTON METRO AREA BASED ON QUALITY OF CARE, PATIENT SAFETY AND REPUTATION IN THIRTEEN ADULT AND FOUR PEDIATRIC SPECIALTIES, INCLUDING CANCER; CARDIOLOGY, HEART & VASCULAR SURGERY; GASTROENTEROLOGY & GI SURGERY, GERIATRICS, NEPHROLOGY; NEUROLOGY & NEUROSURGERY; OBSTETRICS & GYNECOLOGY; OPHTHALMOLOGY; ORTHOPEDICS; PULMONOLOGY & LUNG SURGERY; RHEUMATOLOGY AND UROLOGY. ADDITIONALLY, THE GENERAL RANKED #2 FOR PSYCHIATRY AND #7 FOR DIABETES & ENDOCRINOLOGY, AND #7 FOR EAR, NOSE & THROAT. THE GENERAL HOSPITAL IS RECOGNIZED AS A "MAGNET" HOSPITAL BY THE AMERICAN NURSES CREDENTIALING CENTER. MAGNET DESIGNATION REPRESENTS THE HIGHEST HONOR AVAILABLE FOR NURSING EXCELLENCE AND IS ACHIEVED BY FEWER THAN 7% OF HOSPITALS IN THE UNITED STATES. THE GENERAL HOSPITAL IS LICENSED BY THE DPH TO OPERATE 1,045 BEDS AS OF SEPTEMBER 30, 2023. |
| FORM 990, PART III - PROGRAM SERVICE (ATTACHMENT 1) | MEEI MEEI SPECIALIZES IN DISEASES AND CONDITIONS OF THE EYES, EARS, NOSE, THROAT, HEAD AND NECK. WORLD-RENOWNED FOR CARE, RESEARCH AND TEACHING IN THESE AREAS OF EXPERTISE, MEEI PHYSICIANS AND SCIENTISTS ARE ALSO DRIVEN BY A MISSION TO FIND CURES FOR BLINDNESS AND DEAFNESS. MEEI HAS OPERATED CONTINUOUSLY SINCE ITS FOUNDING IN BOSTON IN 1824 AND LEADS THE HARVARD MEDICAL SCHOOL DEPARTMENTS OF OPHTHALMOLOGY AND OTOLARYNGOLOGY. MEEI OFFERS HIGH-QUALITY AND AFFORDABLE INPATIENT (41 LICENSED BEDS) AND OUTPATIENT CARE AT ITS MAIN CAMPUS IN BOSTON (ADJACENT TO THE GENERAL) AND AT 20 OUTPATIENT SITES IN EASTERN MASSACHUSETTS AND RHODE ISLAND. IN THE 2023-24 U.S. NEWS & WORLD REPORT, MEEI WAS RANKED #4 HOSPITAL IN OPHTHALMOLOGY AND #7 IN OTOLARYNGOLOGY. MEEI JOINED MASS GENERAL BRIGHAM IN 2018. COMMUNITY HOSPITAL SECTOR MASS GENERAL BRIGHAM CURRENTLY OPERATES SEVEN ACUTE CARE COMMUNITY HOSPITALS. IN CONNECTION WITH THE CLOSURE OF UNION HOSPITAL IN LYNN, MASSACHUSETTS, IN 2019, NSMC COMPLETED RENOVATIONS AND PROGRAMMATIC CHANGES AT ITS SALEM, MASSACHUSETTS CAMPUS WHICH ENABLED THE CONSOLIDATION OF UNION HOSPITAL'S INPATIENT SERVICES INTO THE SALEM HOSPITAL SITE. GENERALLY, EACH OF THE MAINLAND COMMUNITY HOSPITALS (CDH, BWFH, NSMC, NWH AND WDH) OFFER A BROAD RANGE OF INPATIENT AND OUTPATIENT SERVICES INCLUDING BUT NOT LIMITED TO SOME OR ALL OF THE FOLLOWING, DEPENDING ON THE PARTICULAR HOSPITAL: MEDICAL/SURGICAL, ORTHOPEDIC, PEDIATRIC, GERIATRIC, GYNECOLOGICAL, OBSTETRICS, EMERGENCY, INTENSIVE CARE, PSYCHIATRIC AND REHABILITATIVE PROGRAMS. THE ISLAND HOSPITALS (MVH AND NCH) HAVE A SOMEWHAT MORE LIMITED RANGE OF INPATIENT AND OUTPATIENT SERVICES, BUT EACH OF THEM HAS LONG-STANDING COLLABORATIONS WITH THE GENERAL IN A VARIETY OF SPECIALTIES AND USES TELEMEDICINE LINKS TO THE GENERAL. MOST OF THE COMMUNITY HOSPITALS OFFER RESIDENCY PROGRAMS IN SELECTED MEDICAL SERVICES AND SPECIALTIES AND SERVE AS TRAINING SITES FOR STUDENTS IN MEDICINE, NURSING AND OTHER FIELDS THROUGH AFFILIATIONS WITH HARVARD UNIVERSITY'S MEDICAL AND DENTAL SCHOOLS AND THE TUFTS UNIVERSITY SCHOOL OF MEDICINE. MASS GENERAL BRIGHAM COMMUNITY HOSPITALS ALSO OFFER EXTENSIVE AMBULATORY CARE SERVICES. FOR EXAMPLE, BWFH OFFERS AN OUTPATIENT CENTER IN BREAST HEALTH CARE, AND OUTPATIENT SERVICES AT NWH INCLUDE A CANCER CENTER, SPINE CENTER, WOMEN'S IMAGING CENTER, CARDIOVASCULAR HEALTH CENTER, JOINT RECONSTRUCTION CENTER, DIABETES CENTER AND AN AMBULATORY SURGERY CENTER. NSMC OFFERS IMAGING SERVICES, CARDIOLOGY TESTING AND SURGICAL SUITES DESIGNED EXCLUSIVELY FOR OUTPATIENT SURGERY AND DIAGNOSTIC ENDOSCOPIC PROCEDURES. PHYSICIAN SECTOR MASS GENERAL BRIGHAM HAS AN EXTENSIVE NETWORK OF APPROXIMATELY 7,200 EMPLOYED AND AFFILIATED PHYSICIANS THAT CONSISTS OF APPROXIMATELY 1,150 COMMUNITY AND ACADEMIC PCPS, APPROXIMATELY 1,600 COMMUNITY SPECIALISTS AND APPROXIMATELY 4,450 ACADEMIC SPECIALISTS. INCLUDED WITHIN THESE PHYSICIAN TOTALS ARE APPROXIMATELY 1,300 PHYSICIANS WHO ARE NOT EMPLOYED BY MASS GENERAL BRIGHAM AND THEREFORE THE FINANCIAL RESULTS OF THEIR PRACTICES ARE NOT INCLUDED IN THE FINANCIAL RESULTS OF THE PHYSICIAN ORGANIZATIONS. THE TWO ACADEMIC PHYSICIAN ORGANIZATIONS, BWPO AND MGPO, EMPLOY SUBSTANTIALLY ALL OF THE STAFF PHYSICIANS WHO PROVIDE HEALTHCARE SERVICES TO PATIENTS AT BWH AND THE GENERAL, RESPECTIVELY. THE BWPO AND MGPO PHYSICIANS ALSO SUPERVISE OTHER PROFESSIONAL AND TECHNICAL PERSONNEL AND TEACH MEDICAL STUDENTS AND RESIDENTS AT BWH AND THE GENERAL, RESPECTIVELY. MEEA EMPLOYS SUBSTANTIALLY ALL OF THE STAFF PHYSICIANS WHO PROVIDE SERVICES AT MEEI'S MAIN CAMPUS AND OUTPATIENT SITES. ITS PHYSICIANS ALSO SUPERVISE MEDICAL STUDENTS AND RESIDENTS. THE COMMUNITY-BASED PHYSICIAN ORGANIZATIONS OF MASS GENERAL BRIGHAM (CDPA, NWMG, NSPG, MGBCP AND WDPC) PROVIDE AMBULATORY PROFESSIONAL SERVICES AND A BROAD VARIETY OF ANCILLARY SERVICES, SUCH AS CLINICAL LABORATORY, IMAGING AND OTHER DIAGNOSTIC AND PROCEDURAL SERVICES, AT A MULTITUDE OF SITES IN EASTERN MASSACHUSETTS OR, IN THE CASE OF CDPA AND WDPC, IN THE NORTHAMPTON, MASSACHUSETTS AND DOVER, NEW HAMPSHIRE AREAS, RESPECTIVELY. THE PHYSICIANS EMPLOYED BY CDPA, NWMG, NSPG AND WDPC ALSO PROVIDE MEDICAL, SURGICAL AND OTHER HEALTH CARE SERVICES TO THE PATIENTS OF THE MASS GENERAL BRIGHAM COMMUNITY HOSPITALS WITH WHICH THEY ARE ASSOCIATED. REHABILITATION CARE SECTOR SR OVERSEES THE MANAGEMENT, DELIVERY, AND INTEGRATION OF NON-ACUTE SERVICES IN THE MASS GENERAL BRIGHAM SYSTEM. SPAULDING REHABILITATION NETWORK. AS SHOWN IN THE TABLE BELOW, THE SPAULDING REHABILITATION NETWORK INCLUDES TWO INPATIENT REHABILITATION FACILITIES (IRFS), ONE LONG-TERM ACUTE CARE (LTAC) FACILITY AND ONE SKILLED NURSING FACILITY (SNF) THAT ACCOMMODATES BOTH SHORT-TERM AND LONGER-TERM PATIENT NEEDS, AS WELL AS 25 OUTPATIENT SITES THROUGHOUT EASTERN MASSACHUSETTS OPERATED BY THE SPAULDING IRFS. SPAULDING BOSTON IS ONE OF THE LARGEST SPECIALTY IRFS IN THE UNITED STATES AND SERVES AS A REFERRAL HOSPITAL FOR ACUTE CARE HOSPITALS IN THE REGION. IN THE 2023-24 U.S. NEWS & WORLD REPORT, SPAULDING BOSTON RANKED #2 IN THE NATION FOR REHABILITATION. SPAULDING REHABILITATION NETWORK NAME AND LOCATION FACILITY TYPE LICENSED BEDS SPAULDING BOSTON IRF 132 SPAULDING CAMBRIDGE LTAC 180 SPAULDING CAPE COD (EAST SANDWICH) IRF 60 SPAULDING BRIGHTON SNF 123 TOTAL 495 HOME HEALTH. HOME HEALTH CARE IS AN ESSENTIAL PART OF THE CONTINUUM OF CARE. IT SUPPORTS THE TRANSITION OF PATIENTS BACK INTO THE COMMUNITY, PROMOTES THEIR INDEPENDENCE, REDUCES THE NEED FOR HOSPITALIZATION AND INSTITUTIONALIZATION AND IS A COST-EFFECTIVE ALTERNATIVE TO INPATIENT CARE. PHH SERVES A GEOGRAPHIC AREA FROM NEWBURYPORT TO THE NORTH OF BOSTON, TO MARLBOROUGH IN THE WEST AND PLYMOUTH IN THE SOUTH. WITH REGIONAL BRANCH OFFICES IN BEVERLY, WALTHAM AND BRAINTREE, PHH EMPLOYS APPROXIMATELY 860 STAFF MEMBERS AND IS ONE OF THE LARGEST HOME HEALTH CARE PROVIDERS IN EASTERN MASSACHUSETTS. MGBHC IS ACCREDITED BY THE JOINT COMMISSION. |
| FORM 990, PART III - PROGRAM SERVICE (ATTACHMENT 1) | PSYCHIATRIC CARE SECTOR IN ADDITION TO THE 181 LICENSED PSYCHIATRIC BEDS LOCATED WITHIN ITS ACUTE CARE HOSPITALS, MASS GENERAL BRIGHAM OPERATES MCLEAN, A FREESTANDING TERTIARY PSYCHIATRIC REFERRAL AND RESEARCH HOSPITAL LICENSED FOR 392 BEDS LOCATED IN BELMONT, MASSACHUSETTS. MCLEAN PROVIDES A CONTINUUM OF INPATIENT, ACUTE AND LONG-TERM RESIDENTIAL, PARTIAL HOSPITALIZATION AND TREATMENT-SPECIFIC OUTPATIENT SERVICES TO CHILDREN, ADOLESCENTS, ADULTS AND GERIATRIC PATIENTS. IT ALSO HAS TWO SPECIALIZED SCHOOLS FOR CHILDREN AND ADOLESCENTS THAT OFFER A RANGE OF THERAPEUTIC SERVICES. IT IS THE LARGEST PSYCHIATRIC TEACHING AFFILIATE OF HARVARD MEDICAL SCHOOL. IN THE 2023-24 U.S. NEWS & WORLD REPORT, MCLEAN RANKED #1 IN THE NATION FOR PSYCHIATRY. MCLEAN BENEFITS FROM A WIDE ARRAY OF CLINICAL AND HOSPITAL REFERRAL SOURCES AND ATTRACTS PATIENTS REQUIRING COMPLEX TREATMENT BOTH FROM THE GREATER EASTERN MASSACHUSETTS REGION AND, TO A DEGREE, NATIONALLY AND INTERNATIONALLY. FOR EACH OF THE LAST 26 YEARS, MCLEAN HAS RECEIVED MORE NATIONAL INSTITUTES OF HEALTH (NIH) RESEARCH FUNDING THAN ANY PRIVATE PSYCHIATRIC HOSPITAL IN THE COUNTRY. MCLEAN'S RESEARCH FOCUS IS ON BASIC BENCHTOP, PRECLINICAL, TRANSLATIONAL AND CLINICAL NEUROSCIENCE. ALL OF MCLEAN'S ACTIVE STAFF OF 220 PHYSICIANS AND PSYCHOLOGISTS HOLD HARVARD MEDICAL SCHOOL APPOINTMENTS. MCLEAN, IN CONJUNCTION WITH THE GENERAL, OPERATES TRAINING PROGRAMS FOR RESIDENTS AND OTHERS IN ALL FIELDS OF PSYCHIATRY AND FOR STUDENTS AND FELLOWS IN PSYCHOLOGY, SUBSTANCE ABUSE TREATMENT AND NEUROLOGY. MCLEAN OFFERS A NUMBER OF CLINICAL PROGRAMS, BOTH ON AND OFF CAMPUS. THESE INCLUDE, BUT ARE NOT LIMITED TO, SATELLITE PROGRAMS AT NINE SITES IN THE GREATER EASTERN MASSACHUSETTS REGION AND ONE IN MAINE THAT OFFER ONE OR MORE OF INPATIENT, RESIDENTIAL, PARTIAL HOSPITAL, SUBSTANCE ABUSE TREATMENT AND INTENSIVE EVALUATION AND DIAGNOSTIC SERVICES FOR PATIENTS OF ALL AGES. MASS GENERAL BRIGHAM PROVIDES EMERGENCY AND OTHER CARE TO PATIENTS REGARDLESS OF THEIR ABILITY TO PAY. THE COST OF PROVIDING THAT CARE IS REFLECTED IN THE STATEMENTS OF OPERATIONS. SERVICES PROVIDED TO CHARITY CARE PATIENTS, FOR WHICH ACUTE CARE HOSPITALS RECEIVE REIMBURSEMENT THROUGH THE STATEWIDE HEALTH SAFETY NET TRUST FUND (HSN), AND TO PATIENTS COVERED UNDER THE MEDICARE AND MEDICAID PROGRAMS GENERATE COSTS FOR WHICH MASS GENERAL BRIGHAM IS NOT FULLY REIMBURSED. FOR CHARITY CARE, MEDICAID AND MEDICARE, THE TOTAL ESTIMATED COST OF SERVICES PROVIDED BY MASS GENERAL BRIGHAM EXCEEDED THE NET REIMBURSEMENT RECEIVED UNDER THESE PROGRAMS BY $2,396,962,000 IN FY 2023. THE ESTIMATED COST OF SERVICES PROVIDED IS EITHER OBTAINED DIRECTLY FROM A COSTING SYSTEM OR IS BASED ON AN ENTITY SPECIFIC RATIO OF COST TO GROSS CHARGES. IN THE LATTER CASE, COST IS DERIVED BY APPLYING THIS RATIO TO GROSS CHARGES ASSOCIATED WITH PROVIDING CARE TO CHARITY CARE, MEDICAID, AND MEDICARE PATIENTS. |
| FORM 990, PART III - PROGRAM SERVICE (ATTACHMENT 2) | RESEARCH: THE CONDUCT OF BIOMEDICAL RESEARCH CONSTITUTES ONE OF THE CORE MISSIONS AND ACTIVITIES OF MASS GENERAL BRIGHAM. IT INCLUDES FUNDAMENTAL BENCH RESEARCH IN ALL OF THE LIFE SCIENCES DISCIPLINES, PATIENT-CENTERED RESEARCH WITHIN THE INPATIENT AND OUTPATIENT SERVICES OF MASS GENERAL BRIGHAM HOSPITALS, CLINICAL TRIALS OF NEW DRUGS AND DEVICES, AS WELL AS HEALTH SERVICES AND EPIDEMIOLOGICAL RESEARCH. MASS GENERAL BRIGHAM HAS THE LARGEST NON-UNIVERSITY-BASED, NON-PROFIT PRIVATE MEDICAL RESEARCH ENTERPRISE IN THE UNITED STATES. HOWEVER, EACH MASS GENERAL BRIGHAM ORGANIZATION WITH MAJOR RESEARCH OPERATIONS THE GENERAL, BWH, SPAULDING BOSTON, MEEI AND MCLEAN ACT AS SEPARATE RESEARCH GRANT RECIPIENTS. THE IMPORTANCE OF RESEARCH AND INNOVATION CANNOT BE OVERSTATED. THE FOUNDING HOSPITALS OF MASS GENERAL BRIGHAM HAVE A LONG TRADITION OF MEDICAL BREAKTHROUGHS, FROM THE FIRST USE OF ETHER FOR SURGERY AT MASSACHUSETTS GENERAL HOSPITAL TO THE FIRST SUCCESSFUL ORGAN TRANSPLANT AT BRIGHAM AND WOMEN'S HOSPITAL. VIRTUALLY EVERY TREATMENT, TEST, DRUG, OR MEDICAL DEVICE IN USE TODAY IS THE RESULT OF SUCCESSFUL RESEARCH FROM THE PAST. THE MASS GENERAL BRIGHAM RESEARCH ENTERPRISE COVERS THE SPECTRUM FROM BASIC SCIENCE TO TRANSLATIONAL AND CLINICAL INVESTIGATION. THIS RESEARCH IS PRIMARILY FUNDED BY THE NATIONAL INSTITUTES OF HEALTH (NIH); BRIGHAM AND WOMEN'S HOSPITAL AND MASSACHUSETTS GENERAL HOSPITAL CONTINUE TO TOP THE LIST OF INDEPENDENT HOSPITALS RECIPIENTS OF NIH FUNDING N THE COUNTRY. MCLEAN HOSPITAL RANKS AS A TOP RECIPIENT AMONG PRIVATE PSYCHIATRIC HOSPITALS. SCIENTISTS FROM A SPECTRUM OF DISCIPLINES ALSO COLLABORATE WITH DISEASE FOUNDATIONS AND INDUSTRY TO ADVANCE OUR KNOWLEDGE AND HELP TRANSLATE OUR DISCOVERIES INTO PATIENT CARE AS SOON AS POSSIBLE. MASS GENERAL BRIGHAM SUPPORTS VARIOUS RESEARCH PROGRAMS TO FACILITATE THE TRANSLATION OF MEDICAL ADVANCES TO ITS PATIENTS. PARTNERS PERSONALIZED MEDICINE (PPM) WAS ESTABLISHED IN 2001 TO REALIZE THE PROMISE OF GENETICS AND GENOMICS IN RESEARCH AND IN MEDICAL PRACTICE. ONE OF THE GOALS OF PPM IS TO HELP ENSURE THAT THE KNOWLEDGE GAINED FROM GENETICS AND GENOMICS BECOMES AN INTEGRAL PART OF DIAGNOSIS, PROGNOSIS AND TREATMENT OF DISEASE (INCLUDING THE DETERMINATION OF THE APPROPRIATE DRUGS) FOR INDIVIDUAL PATIENTS SERVED BY THE MASS GENERAL BRIGHAM ORGANIZATIONS. UNDER THE OVERSIGHT OF PPM, MASS GENERAL BRIGHAM ESTABLISHED A BIOBANK A REPOSITORY OF CONSENTED PATIENT SAMPLES LINKED TO THE ELECTRONIC MEDICAL RECORD AND SUPPLEMENTED WITH HEALTH INFORMATION/FAMILY HISTORY FROM SURVEYS. AS OF SEPTEMBER 30, 2023, OVER 80,000 CONSENTED PATIENTS ARE ENROLLED AND SAMPLES OF MORE THAN 15,000 PATIENTS HAVE BEEN GENOTYPED. BIOBANK DATA AND SAMPLES ARE USED IN RESEARCH TO BETTER UNDERSTAND, PREVENT, AND TREAT MANY DIFFERENT DISEASES. SINCE INCEPTION, THE BIOBANK HAS SUPPORTED OVER $300 MILLION IN FUNDED RESEARCH STUDIES. FOR EXAMPLE, THE BIOBANK ENABLED MASS GENERAL BRIGHAM TO BE AWARDED TWO GRANTS TOTALING $13.6 MILLION AS PART OF THE NIH ELECTRONIC MEDICAL RECORDS AND GENOMICS NETWORK (EMERGE). THE PRIMARY GOAL OF THE EMERGE NETWORK IS TO DEVELOP, DISSEMINATE AND APPLY APPROACHES TO RESEARCH THAT COMBINE DNA BIOREPOSITORIES WITH THE ELECTRONIC MEDICAL RECORD SYSTEM FOR LARGE-SCALE, HIGH-THROUGHPUT GENETIC RESEARCH. MASS GENERAL BRIGHAM IS ABLE TO LEVERAGE ITS INVESTMENT IN ECARE (AN INTEGRATED, ELECTRONIC HEALTH AND ADMINISTRATIVE INFORMATION SYSTEM) AND THE BIOBANK TO IDENTIFY RARE AND COMMON GENE VARIANTS AND EXAMINE HOW THOSE VARIANTS RELATE TO DISEASE RISKS AND TREATMENT EFFECTS. ON A NATIONAL SCALE, MASS GENERAL BRIGHAM WAS INVOLVED IN FORMULATING THE PRECISION MEDICINE INITIATIVE A NATIONAL RESEARCH EFFORT ESTABLISHED IN 2015 TO REVOLUTIONIZE HEALTH CARE AND THE TREATMENT OF DISEASE. THE INITIATIVE AIMS TO GIVE MEDICAL PROFESSIONALS THE RESOURCES THEY NEED TO TARGET SPECIFIC TREATMENTS FOR ILLNESSES AND FURTHER DEVELOP SCIENTIFIC AND MEDICAL RESEARCH, TAKING INTO ACCOUNT INDIVIDUAL DIFFERENCES IN PEOPLE'S GENES, ENVIRONMENTS AND LIFESTYLES. MASS GENERAL BRIGHAM ALONG WITH BOSTON MEDICAL CENTER HAVE FORMED THE NEW ENGLAND PRECISION MEDICINE CONSORTIUM, A REGIONAL RECRUITMENT SITE FOR THE ALL OF US (AOU) BIOMEDICAL RESEARCH PROGRAM THAT IS THE CORNERSTONE OF THE LARGER PRECISION MEDICINE INITIATIVE. THE AOU PROGRAM IS FUNDED AT $1.5 BILLION WITH ANNUAL APPROPRIATIONS OVER 10 YEARS WHICH BEGAN IN 2016, WITH THE GOAL OF RECRUITING ONE MILLION OR MORE VOLUNTEERS TO A NATIONAL BIOBANK. MASS GENERAL BRIGHAM ANTICIPATES RECEIVING APPROXIMATELY $55 MILLION OF THE AOU PROGRAM FUNDING. WITH ADVANCES IN BIG DATA ANALYTICS AND MACHINE LEARNING, HEALTH CARE DATA HAS BECOME THE CORNERSTONE OF MANY NEW DISCOVERIES IN THE DIAGNOSIS AND TREATMENT OF DISEASE. MASS GENERAL BRIGHAM HAS A ROBUST PATIENT DATA ASSET, CREATING TOOLS THAT ALLOW FOR THE COMPLIANT USE OF AND ACCESS TO THIS DATA UNDER THE PURVIEW OF THE RESEARCH INFORMATION SCIENCE AND COMPUTING (RISC) DEPARTMENT. LEVERAGING DATA SCIENTISTS, MACHINE LEARNING/ARTIFICIAL INTELLIGENCE, AND CLINICAL EXPERTISE, RISC DEVELOPS NEW CLINICAL APPLICATIONS FOR CLINICAL CARE AND WITH THE POTENTIAL FOR COMMERCIALIZATION. THE PARTNERS BIG DATA COMMONS IS THE FOUNDATION; LAUNCHED IN 2013 TO INTEGRATE DISPARATE ISLANDS OF PATIENT DATA ONTO A COMMON PLATFORM, IT ALLOWS RESEARCHERS TO ANALYZE DATA FROM MULTIPLE SOURCES SUCH AS RADIOLOGY, THE BIOBANK, PAYOR CLAIMS DATA, AND OTHER CLINICAL OR RESEARCH DATA SOURCES TO BETTER UNDERSTAND PATIENT OUTCOMES AND TREATMENT RESPONSES. TO FURTHER ADVANCE THE USE OF ARTIFICIAL INTELLIGENCE TO BENEFIT HEALTHCARE DELIVERY AND PATIENT OUTCOMES, IN 2017 MASS GENERAL BRIGHAM LAUNCHED THE CENTER FOR CLINICAL DATA SCIENCE (CCDS). CCDS UNIQUELY COMBINES A WEALTH OF HEALTHCARE DATA WITH WORLD-CLASS COMPUTATIONAL RESOURCES, CLINICAL EXPERTISE, AND TECHNICAL KNOW-HOW TO DELIVER REAL-WORLD SOLUTIONS TO PATIENTS AND PHYSICIANS. THE IMPLEMENTATION OF ECARE IS ACCELERATING THE TRANSLATION OF NEW DISCOVERIES AND INVENTIONS TO PATIENT CARE. THIS INCLUDES ENABLING THE INTEGRATION OF TARGETED RESEARCH OPPORTUNITIES AT THE POINT-OF-CARE USING TOOLS BUILT BY MASS GENERAL BRIGHAM, INTEGRATING INNOVATIVE HEALTHCARE APPS WITH THE CLINICAL WORKFLOW TO GUIDE CLINICAL DECISION MAKING, AND ALLOWING PATIENTS TO DIRECTLY ENGAGE WITH RESEARCHERS. RALLY (RALLY.MASSGENERALBRIGHAM.ORG) IS A COMPREHENSIVE, LEADING-EDGE PATIENT RESEARCH RECRUITMENT SOLUTION THAT CONNECTS POTENTIAL VOLUNTEERS WITH RESEARCH OPPORTUNITIES ON THEIR OWN TERMS. RALLY COMPRISES A PUBLICLY SEARCHABLE RESEARCH MARKETPLACE THAT INTERSECTS THE PLAIN-LANGUAGE PRESENTATION OF RESEARCH OPPORTUNITIES WITH AN EVOLVING SET OF CUSTOMER RELATIONSHIP MANAGEMENT (CRM) TOOLS THAT SUPPORT, TRACK, AND OPTIMIZE CONTACT BETWEEN RESEARCH TEAMS AND POTENTIAL RESEARCH VOLUNTEERS. ALL OF THESE EFFORTS ARE KEY COMPONENTS OF A NEW FIVE-YEAR ENTERPRISE DATA & DIGITAL HEALTH (EDDH) INITIATIVE LAUNCHED IN 2019 AIMED AT IMPROVING THE PATIENT EXPERIENCE, BOOSTING DIGITAL INNOVATION AND TRANSFORMING CLINICAL CARE ACROSS THE SYSTEM. THE EDDH INITIATIVE WILL INTEGRATE THE FOUNDATIONAL INVESTMENTS OF MASS GENERAL BRIGHAM IN TECHNOLOGY WITH A NEW DATA AND ANALYTICS ECOSYSTEM TO BRING RICHER INSIGHTS TO PATIENTS AND PHYSICIANS IN REAL-TIME. THROUGH THIS PROGRAM, MASS GENERAL BRIGHAM WILL CREATE A PATHWAY FOR CLINICIANS AND RESEARCHERS TO USE DIGITAL SOLUTIONS TO EXPAND AND SCALE THEIR WORK, INCREASING ACCESS TO CARE FOR PATIENTS IN BOSTON AND BEYOND. MASS GENERAL BRIGHAM CONTINUES TO COLLABORATE WITH HARVARD UNIVERSITY, WHICH ESTABLISHED THE HARVARD CATALYST, AN NIH FUNDED ENTERPRISE DEDICATED TO IMPROVING HUMAN HEALTH THAT INCLUDES OTHER HARVARD MEDICAL SCHOOL AFFILIATED EDUCATIONAL AND HEALTHCARE CENTERS IN THE BOSTON AREA. HARVARD CATALYST WAS INITIALLY FUNDED BY THE NIH IN 2008 WITH A RENEWAL IN 2013. IN 2018, HARVARD CATALYST WAS AWARDED A NEW FIVE-YEAR CLINICAL AND TRANSLATIONAL SCIENCE AWARD WITH ADDITIONAL FUNDING OVER FIVE YEARS FROM HARVARD MEDICAL SCHOOL, HARVARD T.H. CHAN SCHOOL OF PUBLIC HEALTH, BETH ISRAEL DEACONESS MEDICAL CENTER, BOSTON CHILDREN'S HOSPITAL, BWH, DFCI, AND THE GENERAL. |
| FORM 990, PART III - PROGRAM SERVICE (ATTACHMENT 3) | TEACHING: THE MASS GENERAL BRIGHAM HOSPITALS HAVE A LONG TRADITION OF EDUCATING PHYSICIANS, OTHER HEALTHCARE PROFESSIONALS AND BIOMEDICAL SCIENTISTS. GRADUATE MEDICAL EDUCATION. APPROXIMATELY 2,500 RESIDENTS AND FELLOWS IN 300 PROGRAMS IN NEARLY ALL SPECIALTIES AND SUBSPECIALTIES OF MEDICINE ARE APPOINTED TO THE MASS GENERAL BRIGHAM HOSPITALS EACH YEAR. MOST OF THESE ARE BASED AT BWH AND/OR THE GENERAL, BUT MEEI, NWH, NSMC AND SPAULDING BOSTON ALSO SPONSOR GRADUATE MEDICAL EDUCATION PROGRAMS. A NUMBER OF TRAINING PROGRAMS ARE INTEGRATED ACROSS TWO OR MORE MASS GENERAL BRIGHAM HOSPITALS, AND SEVERAL INVOLVE AFFILIATIONS WITH OTHER HARVARD MEDICAL SCHOOL OR TUFTS UNIVERSITY SCHOOL OF MEDICINE (TUSM) TEACHING HOSPITALS. GRADUATE MEDICAL EDUCATION AT MASS GENERAL BRIGHAM UTILIZES BOTH INPATIENT AND AMBULATORY SETTINGS; THE MASS GENERAL BRIGHAM AFFILIATED COMMUNITY HEALTH CENTERS PLAY AN IMPORTANT ROLE IN TRAINING HEALTHCARE PROFESSIONALS AT MASS GENERAL BRIGHAM. BWFH, NWH AND NSMC ARE TEACHING AFFILIATES OF TUSM AND ALSO SERVE AS TRAINING SITES FOR RESIDENCY PROGRAMS FROM BWH AND THE GENERAL. NWH IS ALSO A TRAINING SITE FOR A TUFTS MEDICAL CENTER INTERNAL MEDICINE RESIDENCY PROGRAM AND MANY MEMBERS OF NWH'S MEDICAL STAFF AND THE CHIEFS OF ITS CLINICAL DEPARTMENTS HOLD TUSM FACULTY APPOINTMENTS. HEALTH PROFESSIONS EDUCATION. THE MGH INSTITUTE OF HEALTH PROFESSIONS (THE MGH INSTITUTE) IS AUTHORIZED TO OFFER DOCTORAL, MASTER'S AND SECOND BACHELOR'S DEGREES AND CERTIFICATE PROGRAMS IN COMMUNICATION SCIENCES AND DISORDERS, GENETIC COUNSELING, NURSING, PHYSICIAN ASSISTANT STUDIES, HEALTH PROFESSIONS EDUCATION, PHYSICAL THERAPY, OCCUPATIONAL THERAPY AND REHABILITATION SCIENCES. THE MGH INSTITUTE IS ACCREDITED BY THE NEW ENGLAND COMMISSION OF HIGHER EDUCATION AND BY DISCIPLINE-SPECIFIC ACCREDITING ORGANIZATIONS. FOR EXPERIENTIAL PLACEMENTS, THE INSTITUTE PARTNERS WITH MORE THAN 600 CLINICAL AFFILIATES, INCLUDING COMMUNITY HOSPITALS, COMMUNITY HEALTH CENTERS, HEALTH AND RESEARCH-RELATED INDUSTRIES, HOME HEALTH CARE AGENCIES, MAJOR ACADEMIC MEDICAL CENTERS, PRIVATE PRACTICES, REHABILITATION HOSPITALS, AND SCHOOL-BASED CLINICS. IT CURRENTLY HAS OVER 120 FULL- AND PART-TIME FACULTY MEMBERS AND ENROLLS MORE THAN 1,600 FULL- AND PART-TIME STUDENTS ONSITE AND ONLINE. MEDICAL AND DENTAL STUDENT EDUCATION. BWH AND THE GENERAL ARE MAJOR TEACHING AFFILIATES OF HARVARD MEDICAL SCHOOL AND THE HARVARD SCHOOL OF DENTAL MEDICINE. MOST OF THE ACTIVE CLINICAL AND RESEARCH STAFF OF BWH AND THE GENERAL HOLD HARVARD MEDICAL SCHOOL APPOINTMENTS AND ACTIVELY PARTICIPATE IN BOTH THE CLINICAL AND PRE-CLINICAL TRAINING OF MEDICAL STUDENTS. MCLEAN AND SPAULDING BOSTON ARE PRINCIPAL CLINICAL TEACHING SITES FOR HARVARD MEDICAL SCHOOL STUDENTS IN PSYCHIATRY AND PHYSIATRY, RESPECTIVELY. OTHER EDUCATION AND TRAINING. IN ADDITION, THE GENERAL AND MCLEAN SPONSOR PROGRAMS IN PSYCHOLOGY; BWH AND THE GENERAL PROVIDE TRAINING IN GENERAL DENTISTRY; AND BWH AND THE GENERAL EACH OFFER INTERNSHIPS IN DIETETICS AND HOSPITAL ADMINISTRATION FELLOWSHIPS. COMPLEMENTING THE DIVERSITY OF CLINICAL TRAINING, THERE ARE APPROXIMATELY 1,900 RESEARCH FELLOWS AT BWH AND THE GENERAL, WITH SOME ADDITIONAL FELLOWS AT THE OTHER INSTITUTIONS. THESE PH.D. OR M.D./PH.D. SCIENTISTS PARTICIPATE IN MENTORED RESEARCH EXPERIENCES. MANY ALSO TAKE PART IN ONE OF THE DIDACTIC PROGRAMS AIMED AT BASIC, TRANSLATIONAL, OR CLINICAL AND OUTCOMES RESEARCH THAT ARE OFFERED WITHIN THE MASS GENERAL BRIGHAM SYSTEM. |
| FORM 990, PART VI, SECTION A, LINE 1A | THE FOLLOWING ENTITIES HAVE A DIFFERENCE IN VOTING RIGHTS: - BRIGHAM AND WOMEN'S PHYSICIANS ORGANIZATION, INC. - NANTUCKET COTTAGE HOSPITAL THE FOLLOWING ENTITIES ALSO HAVE AN EXECUTIVE COMMITTEE: - BRIGHAM, INC. - THE BRIGHAM AND WOMEN'S HOSPITAL, INC. - BRIGHAM AND WOMEN'S PHYSICIANS ORGANIZATION, INC. - BRIGHAM & WOMEN'S FAULKNER HOSPITAL, INC. - THE SPAULDING REHABILITATION HOSPITAL CORPORATION - MASS GENERAL BRIGHAM HOME CARE, INC. - SPAULDING NURSING AND THERAPY CENTER BRIGHTON, INC. - SPAULDING HOSPITAL-CAMBRIDGE, INC. - SPAULDING REHABILITATION, INC. - REHABILITATION HOSPITAL OF THE CAPE AND ISLANDS CORPORATION - SHAUGHNESSY-KAPLAN REHABILITATION HOSPITAL, INC. - NANTUCKET COTTAGE HOSPITAL - MARTHA'S VINEYARD HOSPITAL, INC. IN GENERAL, THE EXECUTIVE COMMITTEES HAVE ALL OF THE RESPONSIBILITIES AND AUTHORITY OF THE TRUSTEES BETWEEN MEETINGS OF THE TRUSTEES EXCEPT FOR THE POWERS SPECIFIED IN SECTION 55 OF MASSACHUSETTS GENERAL LAWS, CHAPTER 156B. |
| FORM 990, PART VI, SECTION A, LINE 2 | BRENDA E. HAYNES & ADAM M. KOPPEL - FAMILY RELATIONSHIP CHARLES E. ADAMS & PAMELA L. LAWRENCE - BUSINESS RELATIONSHIP JAMES BRANNEN & MICHAEL BOLDUC - BUSINESS RELATIONSHIP LISA E. CARBONE & GARGI B. COOPER - BUSINESS RELATIONSHIP NIYUM GANDHI & GREGG S. MEYER - BUSINESS RELATIONSHIP PAMELA D. A. REEVE & DAVID ABELMAN - BUSINESS RELATIONSHIP ROBIN A. WALKER & WILLIAM MAURICE COWAN - BUSINESS RELATIONSHIP YUMIN CHOI & ADAM M. KOPPEL - BUSINESS RELATIONSHIP |
| FORM 990, PART VI, SECTION A, LINE 6 | MASS GENERAL BRIGHAM INCORPORATED, A MASSACHUSETTS NONPROFIT CORPORATION, IS EITHER DIRECTLY OR INDIRECTLY THE SOLE MEMBER OF ALL THE SUBORDINATES INCLUDED IN THE MASS GENERAL BRIGHAM INCORPORATED GROUP RETURN EXCEPT FOR THE FOLLOWING SUBORDINATES (WHICH DO NOT HAVE MEMBERS): BRIGHAM MEDICAL RESEARCH & EDUCATION FOUNDATION |
| FORM 990, PART VI, SECTION A, LINE 7A | THE SOLE MEMBER OF EACH ORGANIZATION HAS AUTHORITIES AS SPECIFICALLY ENUMERATED IN EACH ORGANIZATION'S CORPORATE BY-LAWS. THESE AUTHORITIES VARY WIDELY BETWEEN EACH ORGANIZATION. A FEW EXAMPLES OF THE TYPE OF AUTHORITIES GRANTED BY MANY, BUT NOT NECESSARILY ALL, CORPORATE BY-LAWS INCLUDE: - APPOINT A FIRM OF PUBLIC ACCOUNTANTS ANNUALLY TO CONDUCT AN INDEPENDENT AUDIT OF THE CORPORATION'S FINANCIAL AFFAIRS DURING THE FISCAL YEAR LAST ENDED; - REVIEW AND APPROVE ALL PROPOSED CAPITAL AND OPERATING BUDGETS OF THE CORPORATION AND ALL PROPOSED TRANSACTIONS BY THE CORPORATION WHICH INVOLVE AN EXPENDITURE IN EXCESS OF $2,000,000, WHEN SUCH EXPENDITURE HAS NOT BEEN INCLUDED IN A BUDGET PREVIOUSLY APPROVED BY THE MEMBER; - REVIEW AND APPROVE EACH TRANSACTION PROPOSED BY THE CORPORATION WHICH WOULD INVOLVE THE CORPORATION INCURRING DEBT THROUGH LENDER FINANCING; - THE MEMBER MAY ADOPT, AMEND OR REPEAL ANY BYLAW, INCLUDING ANY BYLAWS ADOPTED BY THE TRUSTEES. - THE MEMBER MAY ELECT THE OFFICERS AND TRUSTEES OF THE CORPORATION. - THE MEMBER OR THE TRUSTEES, EACH BY MAJORITY VOTE OF THEIR NUMBER THEN IN OFFICE, MAY SUSPEND OR REMOVE FOR CAUSE ANY TRUSTEE. - THE MEMBER SHALL ENACT, AND FROM TIME TO TIME MAY AMEND A CODE OF CONDUCT AND A POLICY ON CONFLICTS OF INTEREST. PURSUANT TO THE LAWS OF MASSACHUSETTS, THE AUTHORITY FOR THE FOLLOWING ACTIONS IS RESERVED TO THE MEMBER OF THE ORGANIZATION: A. AMEND OR RESTATE THE ARTICLES OF ORGANIZATION B. CONSOLIDATION OR MERGER C. SALE, LEASE, EXCHANGE OR DISPOSITION OF ALL OR SUBSTANTIALLY ALL OF THE ORGANIZATIONS PROPERTY OR ASSETS. |
| FORM 990, PART VI, SECTION A, LINE 7B | EXPLANATION IS INCLUDED IN LINE 7A |
| FORM 990, PART VI, SECTION B, LINE 11B | THE FORM 990 WAS PREPARED AND REVIEWED BY THE MASS GENERAL BRIGHAM INCORPORATED TAX DEPARTMENT. CERTAIN KEY SECTIONS WERE ALSO REVIEWED BY THE MASS GENERAL BRIGHAM CFO AND TREASURER, AND BY THE MASS GENERAL BRIGHAM GENERAL COUNSEL. THE CFO AND TREASURER REVIEWED AND SIGNED THE FORM 990. THE PROCESS FOR PREPARING AND REVIEWING FORM 990 WAS DISCUSSED AT THE MAY 2, 2024 MEETING OF THE AUDIT AND COMPLIANCE COMMITTEE OF THE MASS GENERAL BRIGHAM BOARD OF DIRECTORS. THE COMPENSATION DISCLOSURES WERE PROVIDED TO THE MASS GENERAL BRIGHAM COMPENSATION COMMITTEE WHICH MET ON MAY 7, 2024. THE FINAL FILING VERSION OF THE FORM 990 WAS PROVIDED TO CERTAIN VOTING BOARD MEMBERS PRIOR TO FILING. |
| FORM 990, PART VI, SECTION B, LINE 12C | FOR PURPOSES OF ITS ANNUAL TAX FILING, MASS GENERAL BRIGHAM HAS AN ANNUAL QUESTIONNAIRE PROCESS FOR OBTAINING INFORMATION ON INTERESTS THAT MAY GIVE RISE TO CONFLICTS FROM ALL OFFICERS, DIRECTORS, TRUSTEES AND KEY EMPLOYEES. IN ADDITION, IN CONNECTION WITH MASS GENERAL BRIGHAM'S CONFLICT OF INTEREST POLICY, THE MASS GENERAL BRIGHAM OFFICE FOR INTERACTIONS WITH INDUSTRY AND THE OFFICE OF THE GENERAL COUNSEL WORK TOGETHER TO PERIODICALLY DISTRIBUTE, COLLECT AND REVIEW DISCLOSURE STATEMENTS FROM THESE INDIVIDUALS. THE INFORMATION ON EACH SUCH DISCLOSURE IS REVIEWED BY EACH INDIVIDUAL'S SUPERVISOR (WHO IN THE CASE OF DIRECTORS AND TRUSTEES IS DEEMED TO CONSIST OF THE CHAIRMAN OF THE BOARD AND THE ENTITY'S PRESIDENT/CEO, WHO REVIEW THE DISCLOSURES WITH THE ASSISTANCE OF THE GENERAL COUNSEL OR ATTORNEY REPRESENTATIVES OF HER OFFICE). IN ADDITION, UNDER THE MASS GENERAL BRIGHAM'S CONFLICT OF INTEREST POLICY, ANY TIME AN OFFICER, DIRECTOR, TRUSTEE, OR KEY EMPLOYEE IS AWARE OF A TRANSACTION IN WHICH HIS/HER INTEREST MAY CREATE A CONFLICT, HE/SHE IS REQUIRED TO PROVIDE FULL DISCLOSURE OF THE INTEREST, AND MAY NOT BE INVOLVED IN THE INSTITUTIONAL DECISION-MAKING ABOUT THE TRANSACTION. IN ADDITION, WITH RESPECT TO SUCH TRANSACTIONS, IN APPROPRIATE CIRCUMSTANCES, (I) THE CORPORATION MUST CONSIDER AT LEAST TWO ALTERNATIVE DISINTERESTED COMPETITIVE PROPOSALS; OR MUST DETERMINE THAT TWO SUCH COMPETITIVE PROPOSALS DO NOT EXIST OR THAT IT WOULD BE IMPRACTICAL TO ELICIT OR CONSIDER SUCH COMPETITIVE PROPOSALS; AND (II) THE CORPORATION MUST DETERMINE THAT, NOTWITHSTANDING THE APPARENT CONFLICT, THE TRANSACTION IS FAIR AND REASONABLE TO THE CORPORATION AND IS IN THE BEST INTERESTS OF THE CORPORATION. A WRITTEN RECORD MUST BE MADE OF THESE DETERMINATIONS. FURTHERMORE, TRANSACTIONS THAT PRESENT PARTICULARLY SIGNIFICANT CONFLICTS ARE REVIEWED BY AN INDEPENDENT COMMITTEE OF THE MASS GENERAL BRIGHAM BOARD FOR APPROPRIATE ACTION, WHICH REVIEW IS ALSO DOCUMENTED. AS INSTITUTIONS ARE ADDED TO THE MASS GENERAL BRIGHAM INCORPORATED AND AFFILIATES GROUP RETURN THERE IS A TRANSITION PERIOD. |
| FORM 990, PART VI, SECTION B, LINE 15 | THE ORGANIZATION HAS A BOARD LEVEL COMPENSATION COMMITTEE THAT REVIEWS AND APPROVES THE COMPENSATION FOR CERTAIN OFFICERS AND KEY EMPLOYEES. THE COMMITTEE IS COMPRISED OF MEMBERS OF THE BOARD WHO ARE NOT EMPLOYED BY THE ORGANIZATION, AND NO MEMBER MAY PARTICIPATE IN THE REVIEW AND APPROVAL OF COMPENSATION IF THE MEMBER HAS A CONFLICT OF INTEREST WITH RESPECT TO THAT COMPENSATION ARRANGEMENT. THE COMMITTEE RELIES ON DATA, PROVIDED BY AN INDEPENDENT COMPENSATION CONSULTANT, WHICH INCLUDES COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS, IN FUNCTIONALLY COMPARABLE POSITIONS, AT SIMILARLY SITUATED ORGANIZATIONS. THE DELIBERATIONS AND DECISIONS OF THE COMMITTEE ARE DOCUMENTED IN THE MINUTES OF THE MEETING. THIS REVIEW PROCESS OCCURS ON AN ANNUAL BASIS. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE ORGANIZATION'S GOVERNING DOCUMENTS ARE FILED WITH THE MASSACHUSETTS SECRETARY OF STATE AND THE FINANCIAL STATEMENTS ARE FILED WITH THE MASSACHUSETTS ATTORNEY GENERAL, ALL OF WHICH ARE OPEN TO PUBLIC INSPECTION. THE ORGANIZATION'S CONFLICT OF INTEREST POLICY IS AVAILABLE ON THE ORGANIZATION'S WEBSITE. |
| FORM 990, PART VII : | TITLE KEY: TRUSTEE - T OFFICER - O KEY EMPLOYEE - K |
| FORM 990, PART VII: O & T TITLES | JOSHUA L. ABRAMS, ESQ: O - MCL CHARLES E. ADAMS: O - NSMC, NSPG AALOK V. AGARWALA, MD, MBA: T - MEEA (OFF 02/01/23) IMOIGELE P. AISIKU, MD, MBA: T - BWPO (OFF 07/07/23) PAUL J. ANDERSON, MD, PHD: K - BWH SHELLY A. ANDERSON, MPM: T - HMA (ON 10/01/22, OFF 08/04/23) CARLOS ARELLANO: K - MGBMG SARAH ARNHOLZ, ESQ: O - MGPO WILLIAM G. AUSTEN, JR, MD: HIGHEST COMPENSATED EMPLOYEE MIRANDA S. BALKIN, MD: T - CDPA MAUREEN BANKS: O - RHCI (OFF 01/31/23), SHC (OFF 01/31/23), SKRH (OFF 01/31/23), SNTCB (OFF 01/31/23) KEITH R. BARTLETT: K - WDH TRACY T. BATCHELOR, MD: T - BWPO MEREDITH BEATON-STARR, MS, OTR/L: T - IHP THOMAS L. BEATTY, JR, MD: T - NWH (OFF 06/30/23) KEITH W. BEERS: K - SNTCB CHRISTINE A. BLASKI, MD: T - NSPG CHERI A. BLAUWET, MD: K - SRH SALLY MASON BOEMER: O - GHC, IHP (ON 03/02/23), MGH, MGPO GILES W. BOLAND, MD: O & T - BCP, BWPO; T - BH, BWFH, BWH, MGBCP, MGPO GARRETT J. BOMBA, MD: T - MGBCP MELISSA P. BRENNAN, ESQ: O - RHCI, SHC, SKRH, SNTCB, SR, SRH CARA T. BRICKLEY: K - SRH JAMES A. BRINK, MD: T - BWPO O'NEIL BRITTON, MD: T - MGBHC (ON 10/27/22), MVH (OFF 07/28/23), WNR (OFF 07/28/23) DAVID F. M. BROWN, MD, FACEP: O & T - GHC, MGH, MGPO DEBRA A. BURKE, RN, DNP, MBA, NEA-BC: T - MVH, WNR REAMER LOREN BUSHARDT: K - IHP JUSTIN P. BYRNE, MD: T - NSMC ELLEN L. CAILLE: T - WDPC (OFF 08/07/23) CINDY L. CANNON: O - IHP (OFF 03/02/23) BOB S. CARTER, MD: HIGHEST COMPENSATED EMPLOYEE MICHAEL R. CARTER: O - MGBSP KAREN A. CASPER, MD: K - MVH PAUL R. CASS, DO: T - WDPC EFFIE J. CHAN, ESQ: O - BWPO, HMA, SSEC JULIE C. CHATTOPADHYAY, ESQ: O - NWH, NWMG E. ANTONIO CHIOCCA, MD, PHD: T - BWPO CHRISTOPHER M. COBURN: O & T - PMI JAMES P. COHEN, MD: T - MGBCP YOLONDA L. COLSON, MD, PHD: T - GHC, MGH DAVID P. CONNOLLY: O - MGBCP ZARA R. COOPER, MD: T - BH, BWFH, BWH FINOLA H. COX, PAC: T - WDPC MARY ELIZABETH CUNNANE, MD: O & T - MEEA (O - OFF 09/23/23) WILLIAM T. CURRY, MD: T - FMEEI, MEEI, SERI PAUL G. CUSHING, ESQ: O - NSMC, NSPG JESSICA Z. DACUS, DO: T - CDPA PATRICIA A. D'AMORE, PHD, MBA: K - SERI WILLIAM S. DANFORD, MD: T - WDHF ERNESTO DASILVA, MD: T - NSPG JOEL DEGENAARS: O & T - WDHF, T - WDPC MARCELA G. DEL CARMEN, MD: O & T - MGPO; T - BWPO, GHC, MGBCP, MGH, WDH (OFF 10/31/22) SUSAN DEMPSEY: K - BWFH KEREN DIAMOND: K - MGBHC MARK L. DICK, MD, FACP: T - WDPC TRUNG Q. DO, MA, MBA: T - PMI GERARD M. DOHERTY, MD: T - BH, BWFH, BWH, BWPO TERENCE P. DOORLY, MD: T - NSPG BRANDON E. EARP, MD: HIGHEST COMPENSATED EMPLOYEE KHAMA D. ENNIS, MD, MPH, FACEP: T - CDH, CDHC (OFF 09/30/23), VHCD JEANETTE IVES ERICKSON, RN, DNP, NEA-BC, FAAN: O & T - NCH (O - OFF 10/17/22), NPO (O & T - OFF 10/17/22); T - IHP ATLAS D. EVANS: O - IHP (OFF 07/05/23) JONATHAN M. FALLON, DO: T - CDPA JOHN J.W. FANGMAN, MD: T - MGBCP, WDH (ON 03/10/23), WDPC (ON 08/07/23) JOHN FANIKOS: T - MGBSP KHOSRO FARHAD, MD: T - WDPC MARTHA PYLE FARRELL: K - MEEI JOHN R. FERNANDEZ: O & T - FMEEI (O & T OFF 12/31/22), MEEI (O & T OFF 12/31/22), MGBAS (O & T OFF 12/31/22), MGBMG (O & T OFF 12/31/22), SERI (O & T OFF 12/31/22); T - MEEA (OFF 12/31/22), MGBUC (OFF 12/31/22) CRISTINA R. FERRONE, MD: T - MGPO (OFF 12/31/22) AARON S. FISHMAN: O & T - NPO (O & T OFF 03/24/23); O - NCH (OFF 03/24/23) MATTHEW FISHMAN: T - MGBHPHC TIMOTHY E. FOSTER, MD, MBA, MS: T - NWH CASEY L. FOWLER, MS, RN, ACNP-BC: T - CDPA RONALD FREEMAN: K - SRH ABBEY P. FRIEDLER, ESQ: O - MGBSP (ON 10/25/22) JOANNE M. FUCILE: K - SHC LINDSAY ALLEN GAINER: K - MGBMG NIYUM GANDHI: O & T - BCP, BRF, BWHR, MGBAS, MGBCD, MGBMG, MGBUC (O - ON 04/18/23); O - BH, BWFH, BWH, GHC, MGBHPHC, MGBSP, MGH, RHCI, SHC, SKRH, SNTCB, SR, SRH JOSEPH M. GARASIC, MD: T - NCH (OFF 07/21/23) GARY W. GARBERG: K - MGBHC NARASAIAH GAVINI: K - IHP ROYA GHAZINOURI, PT, DPT, MS: T - IHP VANESSA D. GILBRETH, ESQ: O - BCP (ON 09/20/23), BRF (ON 09/20/23) , BWHR (ON 09/20/23), MICHAEL S. GILMORE, PHD: K - MEEI KEVIN T. GIORDANO, MBA, FACHE: O & T - BWFH (O - ON 09/15/23, T - ON 09/16/23) RICHARD S. GITOMER, MD, MBA: T - BWPO (ON 07/07/23) AIMEE K. GOLBITZ: T - MGBHC (ON 04/13/23) JOSEPH GOLD, MD: K - MCL HILARY J. GOLDBERG, MD, MPH: T - BWPO PATRICK L. GORDAN, MD: K - NSMC ROSEMARY B. GOTTLIEB, ESQ: O - PMI PETER A. GRAPE, MD: O & T - HMA, SSEC; T - BWPO (OFF 07/07/23) JUDI S. GREENBERG, ESQ: O - IHP DAPHNE A. HAAS-KOGAN, MD: T - BH, BWFH, BWH, BWPO (ON 07/07/23) GERARD F. HADLEY: O - BWFH (OFF 03/16/23) MITCHEL B. HARRIS, MD: T - MGPO JAMES L. HEFFERNAN: T - WDH (OFF 08/07/23) MICHELLE W. HELMS, MD: T - CDH, CDHC (OFF 09/30/23), VHCD JOHN B. HERMAN, MD: T - IHP KATHRYN A. HIBBERT, MD: T - MGPO (ON 10/21/22) ROBERT S.D. HIGGINS, MD, MSHA: O & T - BH, BRF, BWH, BWHR; T - BWPO JOHN R. HIGHAM, ESQ: O - GHC, MGBAS, MGBCD, MGBHPHC, MGBMG, MGBUC, MGH MONA Z. HINRICHSEN, MD: T - NSPG EPHRAIM PAUL HOCHBERG, MD: T - CDH, CDHC (OFF 09/30/23), VHCD JEFFREY B. HUGHES, MPH, FACHE: O & T - WDH (O & T OFF 07/23/23), WDHF (O & T OFF 07/23/23), WDPC (O & T OFF 07/23/23) KEVIN J. INMAN, RN, MSN: K - NSMC HELEN C. IRELAND, MD: T - NSPG VICKI A. JACKSON, MD: T - MGBHC ALAN ANTHONY JAMES: T - CDH, CDHC (OFF 09/30/23), MGBHPHC, MVH, VHCD, WDH, WNR STEPHEN R. JENNEY: O - BWPO (OFF 03/17/23), HMA (ON 10/01/22, OFF 03/31/23), SSEC (ON 10/01/22, OFF 03/31/23) ALEX F. JOHNSON: K - IHP BRIAN JOHNSON, MD: T - CDH (ON 01/23/2023, OFF 07/14/2023), VHCD (ON 01/23/2023, OFF 07/14/2023) SEUN JOHNSON-AKEJU, MD: T - MGPO BERNARD R. JONES: T - SSEC (ON 02/01/23) DAINA JUHANSOO, PT, DPT: K - RHCI JAMES D. KANG, MD: T - BWPO (OFF 07/07/23) STEVEN E. KAPFHAMMER: O & T - NSPG (O & T OFF 03/01/23) THOMAS E. KINGSTON, MD: T - NSPG (ON 01/01/23) JAMES M. KIRSHENBAUM, MD: T - BWPO (ON 07/07/23) MARGARET M. KOEHM, MD: T - NCH LUKAS R. KOLM, MD: T - WDH (ON 01/01/23) PAUL M. KONOWITZ, MD, FACS: K - MEEA THOMAS S. KUPPER, MD: T - BWPO (ON 07/07/23) DYLAN C. KWAIT, MD: K - BWFH DAVID A. LAGASSE: O - MCL LAURIE R. LAMOUREUX: O - CDH, CDHC (OFF 09/30/23), CDPA, VHCD MORANA V. LASIC, MD, MED: T - BWPO AMY E. LEE, MBA, MBHA, MJ, FACMPE: O & T - NCH (O & T ON 10/17/22), NPO (O & T ON 10/17/22) REBECCA SYMMES LEE, MD: T - NSPG INGA T. LENNES, MD, MPH, MBA: T - CDH, CDHC (OFF 09/30/23), VHCD ROBERT P. LEVINE, MMS, PA-C: T - CDPA KEITH D. LILLEMOE, MD: T - GHC, MGH DERRICK T. LIN, MD, FACS: K - MEEA CORI LOESCHER, MM, BSN, RN, NEA-BC: K - BWFH JOSEPH LOSCALZO, MD, PHD: T - BCP DAVID N. LOUIS, MD: T - BWPO (ON 07/07/23), MGPO DONNA M. LUKEN: O - MGBHC CHRISTINA LUNDQUIST: K - BWH TIMOTHY M. LYNCH, MBA: T - SSEC (ON 10/01/22, OFF 01/31/23) ARUL MAHADEVAN, MD: T - WDH, WDHF ROBERT T. MCCALL: K - SR DAVID O. MCCREADY, MBA, MHA: O & T - BWFH (O & T OFF 09/15/23) VINCENT T. MCDERMOTT: O & T - NPO (O & T ON 03/24/23), NWMG; O - MGBHC, MVH (ON 07/28/23), NCH (ON 03/24/23), NWH, WDH (ON 08/07/23), WNR (ON 07/28/23) MAURY E. MCGOUGH, MD: T - MGBCP, NSMC, NSPG YANA V. MELNIKOVA, MD: T - WDPC EMILY L. MELTON, ESQ: O - FMEEI, MEEI, SERI GREGG S. MEYER, MD, MSC: O & T - MGBCD, MGBHC; T - MGBAS, MGBMG, MGBUC LIZA HALPERN MEYERHARDT, MD: T - NWH SARI MIETTINEN, MD, MHCM, FAAP: T - CDPA JOAN W. MILLER, MD: O & T - MEEA (O - OFF 09/23/23, ON 09/27/23); T - FMEEI, MEEI, SERI PAULA MILONE-NUZZO, PHD, RN, FAAN, FHHC: O & T - IHP; T - CDH, CDHC (OFF 09/30/23), VHCD ERASMO A. MITRANO: T - MGBSP (ON 05/23/23) BENJAMIN K. MIZELL, MD: T - MEEA (ON 02/01/23) ELLEN A. MOLONEY: O & T - NWH (O & T ON 03/01/23), NWMG (O & T ON 03/01/23) DANIEL M. MORASH: O - BCP, BH, BRF, BWH, BWHR, BWPO (ON 03/17/23), HMA (ON 06/26/23), SSEC (ON 06/26/23) CHARLES A. MORRIS, MD, MPH: T - MGBHC ALBERT NAMIAS, MD: T - NSPG (OFF 12/31/22) KEVIN F. NEILL: O - CDPA MIRIAM L. NEUMAN, MD: T - NSPG MARJORIE L. NICHOLAS: K - IHP BRITAIN W. NICHOLSON, MD: K - GHC ERROL R. NORWITZ, MD, PHD, MBA: O & T - NWH (O & T OFF 03/01/23); T - NWMG (OFF 03/01/23) NAWAL M. NOUR, MD, MPH: T - BH, BWFH, BWH, BWPO (OFF 07/07/23) JOHN J. NOVELLO, MD: T - WDH |
| FORM 990, PART VII: O & T TITLES | TODD M. O'BRIEN, MD: K - NSMC DOST ONGUR, MD, PHD: K - MCL HEATHER M. O'SULLIVAN, MS, AGNP: O & T - MGBHC CYNTHIA N. PACIULLI BARBARITS, MD: T - WDH DENISE PALUMBO, RN, DNP: T - WDPC (ON 08/07/23) SAREH PARANGI, MD: T - NWH (ON 04/12/23) TIMOTHY V. PARSONS, MD: T - CDH, CDHC (OFF 09/30/23), CDPA, VHCD AMAN B. PATEL, MD: HIGHEST COMPENSATED EMPLOYEE GREGORY J. PAULY: T - IHP (ON 09/01/23), NCH (OFF 07/21/23) LAURA S. PEABODY, ESQ: T - MCL DIANE R. PEARL: K - NCH MADELYN M. PEARSON, DNP, RN, NEA-BC: T - IHP JONATHAN R. PERRYMAN, MD: T - NSPG (ON 01/01/23) DANIEL E. PESCH, MD: T - MVH, WNR NANCY J. PETTINARI, MD, CPE: T - MGBCP GEORGE PHILIPPIDES, MD: K - NWH MAY C.M. PIAN-SMITH, MD: T - MGPO NANCY S. PITTMAN: O & T - NPO; O - NCH DAVID S. PLADZIEWICZ, MD: T - MGBCP JEFFREY C. POLLOCK: K - WDH ANAND M. PRABHAKAR, MD: K - NWH ALLYSON L. PRESTON, MD: T - NSPG DAVID L. RABIN, MD: T - NSPG ALI S. RAJA, MD, MBA, MPH, FACHE: T - RHCI, SHC, SKRH, SNTCB, SR, SRH SCOTT L. RAUCH, MD: O & T - MCL ANDREA GEIGER RE, ESQ: O - MGBCP SARATHCHANDRA I. REDDY, MD: T - SSEC CLAUDIA E. REED: O - RHCI, SHC, SKRH, SNTCB, SR, SRH COLEEN M. REID, MD: T - NSMC MITCHELL S. REIN, MD: T - NSPG KERRY J. RESSLER, MD, PHD: K - MCL PHILLIP L. RICE, JR, MD: T - NSMC (OFF 07/01/23), NSPG DAVID J. ROBERTS, MD: O & T - MGBAS (ON 04/07/23), MGBMG (ON 04/04/23), NSMC (O & T OFF 03/01/23); T - MGBUC (ON 04/05/23) JULIAN N. ROBINSON, MD: O & T - NWMG (O & T OFF 06/30/23) DEBRA H. ROGERS: K - MEEI MARC S. RUBIN, MD: K - NSMC ROXANNE C. RUPPEL: O & T - NSMC (O & T ON 03/01/23); T - NSPG DAVID P. RYAN, MD: K - GHC JOAN A. SAPIR: T - RHCI (OFF 06/30/23), SHC (OFF 06/30/23), SKRH (OFF 06/30/23), SNTCB (OFF 06/30/23), SR (OFF 06/30/23), SRH (OFF 06/30/23) DENISE M. SCHEPICI: O & T - MVH, WNR SCOTT L. SCHISSEL, MD, PHD: K - BWFH KEVIN S. SCHLICKE: O & T - MGBHC, PMI ANTHONY J. SCIBELLI, MS, MBA: K - CDH CLAIRE M. SEGUIN: K - MVH THOMAS DEAN SEQUIST, MD: T - FMEEI, MEEI, SERI ANDREW J. SHIN, JD, MPH, MBA: T - CDH, CDHC (OFF 09/30/23), VHCD DAVID SILBERSWEIG, MD: T - RHCI, SHC, SKRH, SNTCB, SR, SRH LUCIA F. SILVA: O - MGBHPHC RACHEL C. SISODIA, MD: T - MGBHC (ON 04/13/23) DAVID O. SMALL: K - NCH DOUGLAS STEWART SMINK, MD, MPH: K - BWFH JONATHAN SNIDER, MD: T - NWH (ON 07/01/23) ALISON M. SOLLEE, MD: T - WDHF MICHELLE C. SPECHT, MD: T - MGPO (ON 01/27/23) LYNN A. STOFER: O & T - MGBCP; T - CDH, CDHC (OFF 09/30/23), VHCD DENIS G. STRATFORD: K - IHP KHALID SYED, MD: T - NSPG (OFF 12/31/22) TRACY A. SYKES, ESQ: O - BCP (OFF 09/20/23), BRF (OFF 09/20/23), BWHR (OFF 09/20/23) SIMON G. TALBOT, MD: T - BWPO STEVEN J. TRINGALE: O & T - MGBHPHC MICHAEL J. VANROOYEN, MD, MPH: T - BWPO (OFF 07/07/23) MARK A. VARVARES, MD, FACS: O & T - MEEA (O - ON 09/27/23); T - FMEEI, MEEI, SERI RON M. WALLS, MD: T - MGBCD ANDREW L. WARSHAW, MD: T - WDH GREGORY R. WARYASZ, MD: HIGHEST COMPENSATED EMPLOYEE LYNNETTE M. WATKINS, MD, MBA: O & T - CDH, CDHC (OFF 09/30/23), VHCD; T - CDPA, MGBCP KENNETH R. WHITE: K - IHP KEVIN B. WHITNEY: K - MGBHC CAROLANN WILLIAMS: O & T - FMEEI (T - ON 01/01/23), MEEI (T - ON 01/01/23), SERI (T - ON 01/01/23); T - MEEA (ON 02/01/23) SHEILA M. WOOLLEY: K - WDH ROSS D. ZAFONTE, DO: O & T - RHCI (O ON 02/01/23), SHC (O ON 02/01/23), SKRH (O ON 02/01/23), SNTCB (O ON 02/01/23), SR, SRH DAVID ABELMAN: T - MGBCP CLARITZA N. ABREU: T - MGBHPHC GERALDINE ACUA SUNSHINE: T - GHC (ON 03/31/23), MGH (ON 03/31/23) CAROLINA ALARCO: T - MGPO SETH D. ALEXANDER: T - NWH JOAN LORING ALFOND: T - FMEEI, MEEI, SERI STEVEN M. ALTSCHULER, MD: T - BWPO STEVEN L. ANTONAKES: T - NSMC ROBERT G. ATCHINSON: T - FMEEI, MEEI, SERI MINNIE V. BAYLOR-HENRY: T - FMEEI, MEEI, SERI FRASER BENNETT BEEDE: T - CDH, CDHC (OFF 09/30/23), CDPA, VHCD SHELLY C. BERNSTEIN, MD, PHD: T - MGBCP (ON 09/12/23) MARGARET E. BOASBERG: T - MGPO (ON 01/27/23) MICHAEL BOLDUC, ESQ: O & T - WDH (O OFF 08/07/23), WDPC JEANINE M. BORTHWICK: T - NCH KATRINE S. BOSLEY: T - FMEEI, MEEI, SERI JAMES R. BRANNEN: T - WDH, WDPC NATHAN BRYANT, EDD: T - NSMC BRUCE M. BULLEN: T - MVH, WNR THOMAS P. CAINE: O & T - CDH, CDHC (OFF 09/30/23), VHCD JAMES A. CANFIELD, BA: T - IHP LISA E. CARBONE: T - NSMC, NSPG RICHARD CARD: T - WDHF (OFF 04/15/23) MICHAEL CARELLA: T - WDHF MICEAL CHAMBERLAIN: T - BH (ON 09/12/23), BWFH (ON 09/20/23) , BWH (ON 09/20/23) YUMIN CHOI: T - NWH DAVID R. CLANCEY: T - NSMC (OFF 07/01/23) LISA CLAREY-LAWLER: T - NCH PHILLIP L. CLAY, PHD: T - RHCI, SHC, SKRH, SNTCB, SR, SRH CHRISTOPHER T. COLLINS: T - NWH RICHARD CONLEY: T - WDHF JOHN P. CONNAUGHTON: T - BH, BWFH, BWH GARGI B. COOPER, FNP: T - NSMC LUCY S. CORCHADO: T - NSMC (ON 02/15/23) WILLIAM MAURICE COWAN: T - GHC (OFF 07/18/23), MGH MEGAN M. CRAIGEN: T - BH, BWFH, BWH SUSAN C. CRAMPTON: T - MVH, WNR CYNTHIA K. CURME: T - NWH KAREN D. CURRAN, MBA, CHFC, CFP: O & T - CDH, CDHC (OFF 09/30/23), VHCD MICHAEL A. CURRY, ESQ: T - MGBHPHC (ON 07/18/23) PETER A. D'ARRIGO, JR, BS: T - IHP CHARLES DE GUNZBURG: T - FMEEI, MEEI, SERI LINDA DE RENZO, ESQ: T - NWH, NWMG JANE L. DELGADO, PHD, MS: T - MCL ELIAS T. DEMAKES: T - NSMC (ON 02/01/23) DAVID C. DESWERT: T - CDH (ON 09/19/23), CDHC (ON 09/19/23, OFF 09/30/23), VHCD (ON 09/19/23), CYNTHIA M. DEYSHER: T - FMEEI, MEEI, SERI NOVA O. DIOP: T - IHP (ON 09/01/23) DUTROCHET J. DJOKO: T - NSMC KATHLEEN A. DOWCETT: T - NWH JEFFREY M. DRAZEN, MD: T - NCH JACKIE EASTWOOD: T - WDHF (OFF 09/07/23) PAUL B. EDGERLEY: T - GHC, MGH DEBORAH C. ENOS: T - BH, BWFH, BWH ARIELLE R. FARIA: T - MVH, WNR JULIETTE E. FAY: T - MVH, WNR MICHAEL S. FERRARA, PHD: O & T - WDH (O ON 08/07/23) JOANNE J. FINCK: T - CDH, CDHC (OFF 09/30/23), VHCD ANNE M. FINUCANE: T - BH, BWFH, BWH DAVID B. FISCHER: T - RHCI, SHC, SKRH, SNTCB, SR, SRH JOHN F. FISH: T - BH, BRF, BWFH, BWH, BWHR JUDITH A. FONG, BA, RN: T - RHCI, SHC, SKRH, SNTCB, SR, SRH BRUCE FREEDMAN: T - NWH YVONNE GARCIA ACHAB: T - RHCI, SHC, SKRH, SNTCB, SR, SRH LAUREN A. GEDDES, MD: T - MGBCP (OFF 09/12/23) CHARLES K. GIFFORD: T - NCH THOMAS P. GLYNN, III, PHD: T - IHP BENJAMIN A. GOMEZ: T - NWH IRMA V. GONZLEZ: T - CDH, CDHC (OFF 09/30/23), VHCD SALLY M. GRIGGS: T - CDH, CDHC (OFF 09/30/23), VHCD REBECCA L. HAAG: O & T - MVH, WNR CONSTANCE N. HADLEY, PHD: T - MCL KAREN R. HALE: T - BH, BWFH, BWH JOSEPH HARRINGTON, MD: T - MGBCP BRENDA E. HAYNES, MD: T - NWH BRENT L. HENRY, ESQ: T - MVH, WNR EVE J. HIGGINBOTHAM, SM, MD, ML: T - FMEEI, MEEI, SERI EUGENE D. HILL, III: T - FMEEI, MEEI, SERI LINDA A. HILL, PHD: T - BH, BWFH, BWH RICHARD E. HOLBROOK: T - MCL, MGBHPHC ALBERT A. HOLMAN, III: O & T - BH, BWFH, BWH NANCY LYLE HOWLAND: T - FMEEI, MEEI, SERI ROBERT S. HUCKMAN, PHD: T - BH, BWFH, BWH, BWPO JAMES W. HUNT, JR: T - MGBHPHC (OFF 07/18/23) DAVID W. IVES: T - NSMC MICHAEL R. JAFF, DO, FACP, FACC: T - MVH, WNR ANNE JAMIESON: O & T - WDH; T - WDHF MELISSA WEINER JANFAZA: T - BH (OFF 09/12/23), BWFH (OFF 09/20/23), BWH (OFF 09/20/23) ROBERT E. JOHNSON, PHD: T - IHP DANIEL G. JONES: T - RHCI, SHC, SKRH, SNTCB, SR, SRH ELIZABETH JOYCE, BS: T - IHP DIANE E. KANEB: T - FMEEI (OFF 07/30/23), MEEI (OFF 07/30/23), SERI (OFF 07/30/23) KAREN T. KAPLAN: T - BH, BWFH, BWH STEVEN M. KAYE: T - BH, BWFH, BWH MOLLY A. KEEGAN: T - CDH (ON 09/19/23), CDHC (ON 09/19/23, OFF 09/30/23), VHCD (ON 09/19/23), PAUL G. KELLIHER: O & T - CDPA; T - CDH, CDHC (OFF 09/30/23), VHCD CHRISTOPHER J. KELLY: T - NWH GERARD J. KENEALLY: T - NCH RESHMA KEWALRAMANI, MD: T - GHC, MGH LESLEE L. KILEY: T - MGBHPHC ROBERT CHRISTOPHER KNAPP: T - FMEEI (OFF 03/23/23), MEEI (OFF 03/23/23), SERI (OFF 03/23/23) JOHN H. KNOWLES, JR, MBA, MPH: T - IHP ADAM M. KOPPEL, MD, PHD: T - NWH JONATHAN A. KRAFT: T - GHC, MGH, MGPO JOSHUA M. KRAFT: T - BH, BWFH, BWH STEPHEN KULIK: T - CDH, CDHC (OFF 09/30/23), VHCD MICHELLE E. KURTZ, CPA: T - WDH ELIZA B. LAKE: T - CDH, CDHC (OFF 09/30/23), VHCD TERRI LALLY, MD: T - WDH (OFF 12/31/22) RENE M. LANDERS, JD: T - GHC, MGH NANCY A. LAPOINTE: T - CDH, CDHC (OFF 09/30/23), VHCD GLORIA CORDES LARSON, ESQ: T - MCL THOMAS H. LAUER: T - FMEEI, MEEI, SERI PAMELA L. LAWRENCE: T - NSPG THOMAS F. LEVASSEUR: T - WDHF DONNA LEVIN: T - MGBCP BEN S. LEVITAN: T - RHCI, SHC, SKRH, SNTCB, SR, SRH JAY LEVY: T - WDHF RONALD J. LEVY: T - NCH DAVID H. LONG: T - GHC, MGH STACEY LUCCHINO: T - MCL (OFF 07/18/23) |
| FORM 990, PART VII: O & T TITLES | HUSSEINI K. MANJI, MD, FRCPC: T - MCL JULIE A. MARRIOTT: T - NWH CARL J. MARTIGNETTI: T - GHC, MGH JOSEFINA MARTINEZ STAMATOS: T - BH, BWFH, BWH TERENCE A. MCGINNIS: T - NSPG ANTONIA G. MCGUIRE, RN, MPH: T - MGBHPHC JEROME T. MCMANUS: T - NSMC PATRICK R. MCSWEENEY, MD: T - MGBCP (ON 09/12/23) RAUL MEDINA: T - MGBHPHC ROSHEN MENON: T - NWH (ON 07/01/23) C. ANN MERRIFIELD: T - RHCI (OFF 06/30/23), SHC (OFF 06/30/23), SKRH (OFF 06/30/23), SNTCB (OFF 06/30/23), SR (OFF 06/30/23), SRH (OFF 06/30/23) CARLA S. MEYERS, ESQ: O & T - WDHF (O & T OFF 09/07/23) MARLA S. MICHEL: T - CDH (OFF 09/19/23), CDHC (OFF 09/30/23), VHCD CATHY E. MINEHAN: T - MCL JAMES F. MOONEY, III: T - GHC, MGH LAURA BARKER MORSE: T - MGPO VALERIE MOSLEY: T - MCL CRAIG H. MUHLHAUSER: T - NCH TIMOTHY R. MULLEN: T - NCH GEOFFREY NESS: O & T - WDHF (O ON 09/07/23) PETER NESSEN: O & T - MVH, WNR JACQUELINE N. NKUEBE, MBA, MPP: T - BWPO (ON 07/07/23) NITIN NOHRIA: T - GHC, MGH JOHN N. NUNNELLY: T - CDPA MARK E. NUNNELLY: T - BH, BWFH, BWH MICHAEL F. O'CONNELL, ESQ: T - BWPO (OFF 07/07/23) KATHRYN P. O'NEIL: T - MCL (ON 07/18/23) PATRICIA B. PALACIOS, JD: T - IHP ANTHONY F. PAREDES, FNP-BC: T - IHP DIANE B. PATRICK, ESQ: T - GHC, MGH RICHARD A. PENN: T - RHCI, SHC, SKRH, SNTCB, SR, SRH ELISABETH SCHADAE PERCELAY: T - NCH LIZETTE M. PREZ-DEISBOECK: T - GHC, MGH ADELENE Q. PERKINS: T - GHC, MGH ANGELLEEN PETERS-LEWIS, PHD, RN, FAAN: T - IHP (OFF 03/02/23) JULIEN L. PHAM, MD, MPH: T - IHP MELISSA D. PHILBRICK: T - NCH TEVIA K. POLLARD: T - RHCI (ON 07/01/23), SHC (ON 07/01/23), SKRH (ON 07/01/23), SNTCB (ON 07/01/23), SR (ON 07/01/23), SRH (ON 07/01/23) JENNIFER L. GUCKEL PORTER: T - MCL (OFF 07/18/23) COLLEEN RICHARDS POWELL: T - MGPO RODNEY C. PRATT: T - FMEEI, MEEI, SERI MARY G. PUMA: T - NSMC KYLE STEPHEN RAY RABBITT, CPA: T - IHP PHILLIP TERRY RAGON: T - GHC, MGH CHANDRA RAMANATHAN, PHD: T - MCL DEBORAH DUBE REED: T - WDH PAMELA D. A. REEVE: T - MGBCP, MGPO NANCY R. REEVES: T - CDH, CDHC (OFF 09/30/23), VHCD ALVIN L. REYNOLDS, JR: T - MGBCP DARIN C. ROARK, BSN, MBA, FACHE: O & T - WDH (O & T ON 07/24/23), WDHF (O & T ON 07/24/23), WDPC (O & T ON 07/24/23) CARMICHAEL S. ROBERTS, PHD: T - MGPO INGO F. ROEMER: T - WDH, WDPC WILLIAM J. ROMAN: T - MVH, WNR ZACHARY ROSENBURG: T - MVH (ON 03/31/23), WNR (ON 03/31/23) VINCENT D. ROUGEAU: T - NWH JOSEPH F. RYAN, ESQ: T - RHCI, SHC, SKRH, SNTCB, SR, SRH MELANIE R. SABELHAUS: T - NCH LINDA J. SALLOP: T - RHCI, SHC, SKRH, SNTCB, SR, SRH JOHN P. SALMON: T - WDH, WDHF, WDPC ROBERTO J. SANTAMARIA: T - NCH (ON 07/21/23) ERIC D. SCHLAGER: T - BH (OFF 09/12/23), BWFH (OFF 09/20/23), BWH (OFF 09/20/23) SCOTT A. SCHOEN: T - RHCI (OFF 06/30/23), SHC (OFF 06/30/23), SKRH (OFF 06/30/23), SNTCB (OFF 06/30/23), SR (OFF 06/30/23), SRH (OFF 06/30/23) MARK SCHWARTZ: T - GHC, MGH S. CHRISTOPHER SCOTT: T - MVH, WNR SHIRLEY SINGLETON: T - NSMC (OFF 07/01/23) EILEEN H. SIVOLELLA: T - FMEEI, MEEI, SERI CANDACE LAPIDUS SLOANE, MD: T - NWH PAULA NESS SPEERS: T - RHCI, SHC, SKRH, SNTCB, SR, SRH CHARLES P. STAELIN, PHD: T - CDPA MICHAEL STEINBERG: T - WDHF (OFF 09/07/23) DANIEL J. SULLIVAN: T - IHP (ON 09/01/23) CYNTHIA A. SUOPIS, PHD: T - CDH, CDHC (OFF 09/30/23), VHCD JAMES D. TAICLET: T - BH, BWFH, BWH ALEXANDER L. THORNDIKE: T - BH, BWFH, BWH THOMAS TORR, ESQ: T - WDHF JONATHAN M. UHRIG: O & T - FMEEI, MEEI, SERI CAROL A. VALLONE: T - MCL DAVID VERNO, CPA: T - WDHF JOAN M. VITELLO-CICCIU, RN, PHD: T - NWH, NWMG DAVID O. VOLPI, MD: T - NCH JOSEF H. VON RICKENBACH: T - MCL ROBIN A. WALKER, JD: T - GHC, MGH MARTIN J. WALSH: T - BH (ON 09/12/23), BWFH (ON 09/20/23) , BWH (ON 09/20/23) CATHERINE S. WARD, MT (ASCP): T - NCH BENAREE P. WILEY: T - RHCI, SHC, SKRH, SNTCB, SR, SRH PRATT N. WILEY: T - BH, BWFH, BWH ANNE M. WILKINS: T - MGBHPHC MICHELLE A. WILLIAMS, SCD: T - MCL MARION E. WINFREY, EDD, RN: T - NSMC, NSPG AMY M. WINSLOW: T - BWPO (OFF 04/12/23) ELIZABETH B. WRIGHT: T - NCH KRISHNA C. YESHWANT, MD, MBA: T - BH (OFF 09/12/23), BWFH (OFF 09/20/23), BWH (OFF 09/20/23) GWILL YORK: T - BH, BWFH, BWH, RHCI, SHC, SKRH, SNTCB, SR, SRH NICHOLAS S. ZEPPOS: T - MCL |
| FORM 990, PART XI, LINE 9: | CHANGE IN FUNDED STATUS OF DEFINED BENEFIT PLAN 12,709,579. OTHER -8,923,887. |
| FORM 990, PART XII, LINE 2C | NO CHANGES FROM PRIOR YEAR. |
| Software ID: | |
| Software Version: |